Empresa 2cureX AB (publ) Nasdaq Stockholm
Acciones
SE0010468124
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 48 | 01/02/21 | |
Grith Hagel
FOU | Founder | 65 | 01/01/06 |
Ole Thastrup
FOU | Founder | 71 | 01/01/06 |
Raphael Gruber
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/07/22 |
Jacob Thastrup
PRN | Corporate Officer/Principal | - | - |
Tabea Sturmheti
PRN | Corporate Officer/Principal | 39 | 01/01/17 |
Corporate Officer/Principal | 59 | 01/08/21 | |
Manuel Fernández
LAW | General Counsel | - | 21/04/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ole Thastrup
FOU | Founder | 71 | 01/01/06 |
Chairman | - | 14/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 17 602 916 | 7 467 585 ( 42,42 %) | 0 | 42,42 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-16,10 % | 11,41 mil M | |
+67,65 % | 3814,11 M | |
-30,20 % | 2301,19 M | |
-14,31 % | 2156,49 M | |
-26,03 % | 1555,71 M | |
+36,95 % | 1189,91 M | |
-2,40 % | 760 M | |
-38,57 % | 444 M | |
+13,72 % | 339 M |